Literature DB >> 15033996

Distribution of soluble epoxide hydrolase and of cytochrome P450 2C8, 2C9, and 2J2 in human tissues.

Ahmed E Enayetallah1, Richard A French, Michael S Thibodeau, David F Grant.   

Abstract

Soluble epoxide hydrolase (sEH) hydrolyzes a wide variety of endogenous and exogenous epoxides. Many of these epoxides are believed to be formed by cytochrome P450 epoxygenases. Here we report the distribution of sEH and cytochrome P450 epoxygenases 2C8, 2C9, and 2J2 by immunohistochemistry. A large number of different tissues from different organs were evaluated using high-throughput tissue microarrays. sEH was found in the liver, kidney, and in many other organs, including adrenals, pancreatic islets, pituitary gland, lymphoid tissues, muscles, certain vascular smooth muscles, and epithelial cells in the skin, prostatic ducts, and the gastrointestinal tract. Immunolabeling for sEH was highly specific for particular tissues and individual cell types. CYP2C9 was also found in almost all of these organs and tissues, suggesting that 2C9 and sEH are very similar in their tissue-specific patterns of expression. CYP2C8 and 2J2 were also widely distributed in human tissues but were less frequently associated with sEH. The results suggest potentially distinct pathways of endogenous fatty acid epoxide production and hydrolysis in a variety of human tissues.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15033996     DOI: 10.1177/002215540405200403

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  93 in total

1.  N-terminal domain of soluble epoxide hydrolase negatively regulates the VEGF-mediated activation of endothelial nitric oxide synthase.

Authors:  Hsin-Han Hou; Bruce D Hammock; Kou-Hui Su; Christophe Morisseau; Yu Ru Kou; Susumu Imaoka; Ami Oguro; Song-Kun Shyue; Jin-Feng Zhao; Tzong-Shyuan Lee
Journal:  Cardiovasc Res       Date:  2011-11-08       Impact factor: 10.787

Review 2.  The importance of the lipoxygenase-hepoxilin pathway in the mammalian epidermal barrier.

Authors:  Agustí Muñoz-Garcia; Christopher P Thomas; Diane S Keeney; Yuxiang Zheng; Alan R Brash
Journal:  Biochim Biophys Acta       Date:  2013-09-07

3.  Cytochrome P450 2J2 is highly expressed in hematologic malignant diseases and promotes tumor cell growth.

Authors:  Chen Chen; Xin Wei; Xiaoquan Rao; Jun Wu; Shenglan Yang; Fuqiong Chen; Ding Ma; Jianfeng Zhou; Ryan T Dackor; Darryl C Zeldin; Dao Wen Wang
Journal:  J Pharmacol Exp Ther       Date:  2010-10-28       Impact factor: 4.030

4.  Development of a high throughput cell-based assay for soluble epoxide hydrolase using BacMam technology.

Authors:  Wensheng Xie; Xiaoyan Tang; Quinn Lu; Robert S Ames; Steven J Ratcliffe; Hu Li
Journal:  Mol Biotechnol       Date:  2010-07       Impact factor: 2.695

5.  Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Craig R Lee; Kari E North; Molly S Bray; Myriam Fornage; John M Seubert; John W Newman; Bruce D Hammock; David J Couper; Gerardo Heiss; Darryl C Zeldin
Journal:  Hum Mol Genet       Date:  2006-04-04       Impact factor: 6.150

6.  Detection of human CYP2C8, CYP2C9, and CYP2J2 in cardiovascular tissues.

Authors:  Tracy C Delozier; Grace E Kissling; Sherry J Coulter; Diana Dai; Julie F Foley; J Alyce Bradbury; Elizabeth Murphy; Charles Steenbergen; Darryl C Zeldin; Joyce A Goldstein
Journal:  Drug Metab Dispos       Date:  2007-01-12       Impact factor: 3.922

7.  Soluble epoxide hydrolase contamination of specific catalase preparations inhibits epoxyeicosatrienoic acid vasodilation of rat renal arterioles.

Authors:  Kathryn M Gauthier; Lauren Olson; Adam Harder; Marilyn Isbell; John D Imig; David D Gutterman; J R Falck; William B Campbell
Journal:  Am J Physiol Renal Physiol       Date:  2011-07-13

Review 8.  Xenobiotica-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models.

Authors:  F Oesch; E Fabian; Robert Landsiedel
Journal:  Arch Toxicol       Date:  2018-06-18       Impact factor: 5.153

9.  Selective inhibitors of CYP2J2 related to terfenadine exhibit strong activity against human cancers in vitro and in vivo.

Authors:  Chen Chen; Guiling Li; Wanmin Liao; Jun Wu; Liu Liu; Ding Ma; Jianfeng Zhou; Reem H Elbekai; Matthew L Edin; Darryl C Zeldin; Dao Wen Wang
Journal:  J Pharmacol Exp Ther       Date:  2009-03-16       Impact factor: 4.030

10.  Upregulation of soluble epoxide hydrolase in proximal tubular cells mediated proteinuria-induced renal damage.

Authors:  Qian Wang; Wei Pang; Zhuan Cui; Junbao Shi; Yan Liu; Bo Liu; Yunfeng Zhou; Youfei Guan; Bruce D Hammock; Yue Wang; Yi Zhu
Journal:  Am J Physiol Renal Physiol       Date:  2012-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.